AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2019
Mar 19, 2019
35221_dirs_2019-03-19_ded4fe39-5821-4929-9416-dbe310df260a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2019-03-15
Reporting Person: MCGRATH DENNIS M (EVP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-15 | Common Stock | A | 500000 | — | Acquired | 524000 | Direct |
Footnotes
F1: The issuer granted 500,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.
More from PAVmed Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 23